No price series to chart for BCTXZ.
BCTXZ is not in the screener universe; fundamentals are unavailable.
No price history for BCTXZ — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for BCTXZ, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| LLY | ELI LILLY & Co | $1.14T | 52.7 |
| JNJ | JOHNSON & JOHNSON | $639.90B | 24.1 |
| ONC | BeOne Medicines Ltd. | $472.90B | 1722.2 |
| ABBV | AbbVie Inc. | $465.20B | 111.6 |
| MRK | Merck & Co., Inc. | $321.97B | 17.9 |
| ABT | ABBOTT LABORATORIES | $188.12B | 29.0 |
| PFE | PFIZER INC | $143.34B | 18.5 |
| BMY | BRISTOL MYERS SQUIBB CO | $128.85B | 18.2 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $122.67B | 31.5 |
| REGN | REGENERON PHARMACEUTICALS, INC. | $65.34B | 16.8 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $40.45B | 28.7 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | $38.01B | 123.0 |